Active Stocks
Fri Jun 20 2025 15:58:34
  1. Itc share price
  2. 418.45 0.59%
  1. Reliance Industries share price
  2. 1,464.65 2.16%
  1. Tata Steel share price
  2. 151.90 0.63%
  1. Tata Consultancy Services share price
  2. 3,434.35 0.29%
  1. Tata Motors share price
  2. 676.10 0.58%
Business News/Market/Market Stats/    Strides Pharma Science

STRIDES PHARMA SCIENCE SUMMARY

Strides Pharma Science is trading 1.76% lower at Rs 829.85 as compared to its last closing price. Strides Pharma Science has been trading in the price range of 849.30 & 822.80. Strides Pharma Science has given 28.18% in this year & -1.04% in the last 5 days.

 

Strides Pharma Science has TTM P/E ratio 18.46 as compared to the sector P/E of 22.66. There are 2 analysts who have initiated coverage on Strides Pharma Science. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.

 

The company posted a net profit of 82.19 Crores in its last quarter.

 

Listed peers of Strides Pharma Science include Shilpa Medicare (-1.61%), Aarti Pharmalabs (2.27%), Strides Pharma Science (-1.76%) etc.

 

Strides Pharma Science has a 28.3% promoter holding & 71.7% public holding.

FAQs about Strides Pharma Science

Strides Pharma Science is trading at 829.85 as on 20 Jun, 2025 3:29:01 PM. This is -1.76% lower as compared to its previous closing price of 844.7
The market capitalization of Strides Pharma Science is 7627.59 Cr as on 20 Jun, 2025 3:29:01 PM.
The average broker rating on Strides Pharma Science is Strong Buy. The breakup of analyst rating is given below -
  • 0.00 analysts have given a strong sell rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a hold rating
  • 1 analysts have given a buy rating
  • 1 analysts have given a strong buy rating
The 52 wk high for Strides Pharma Science is 901.75 whereas the 52 wk low is 412.71
Strides Pharma Science can be analyzed on the following key metrics -
  • TTM P/E: 18.46
  • Sector P/E: 22.66
  • Dividend Yield: 0.47%
  • D/E ratio: -
Strides Pharma Science reported a net profit of 3593.46 Cr in 2025.
Recommended For You